WES, RNASeq and CNV Analysis of NF1-Associated Atypical Neurofibromas
Demographics (3)
- AGE_ONSET - Disease onset age (phv00430022.v1.p1)
- SEX - Sex (phv00430015.v1.p1)
- SEX - Self-reported sex (phv00430021.v1.p1)
Disease Events (5)
- AFFECTION_STATUS - Case control status of the subject for Neurofibromatosis type 1 (NF1) (phv00430020.v1.p1)
- HISTOLOGICAL_TYPE - Cell or tissue type or subtype of sample (phv00430028.v1.p1)
- TUMOR_GRADE - Tumor grade of sample (phv00430032.v1.p1)
- TUMOR_STAGE - Tumor stage of sample (phv00430031.v1.p1)
- TUMOR_TREATMENT - Type of tumor treatment for sample (phv00430033.v1.p1)
Other (21)
- ANALYTE_TYPE - Analyte Type (phv00430026.v1.p1)
- BODY_SITE - Body site where sample was collected (phv00430025.v1.p1)
- CONSENT - Consent group as determined by DAC (phv00430793.v1.p1)
- FAMILY_ID - Family ID (phv00430011.v1.p1)
- FATHER - Father's Subject ID (phv00430014.v1.p1)
- GENOTYPING_CENTER - Name of the center which conducted genotyping (phv00430034.v1.p1)
- IS_TUMOR - Tumor status (phv00430027.v1.p1)
- KRAS - Somatic mutation in KRAS (Entrez GeneID: 3845) (phv00430023.v1.p1)
- MOTHER - Mother's Subject ID (phv00430013.v1.p1)
- MZ_TWIN_ID - Twin ID for monozygotic twins and multiples. An MZ_TWIN_ID is not provided for dizygotic twins or multiples. (phv00430016.v1.p1)
- PRIMARY_METASTATIC_TUMOR - Primary tumor, metastasis, or transformed cell line (phv00430029.v1.p1)
- PRIMARY_TUMOR_LOCATION - Primary tumor location (phv00430030.v1.p1)
- SAMPLE_ID - Sample ID (phv00430024.v1.p1)
- SAMPLE_ID - Sample ID (phv00430796.v1.p1)
- SEQUENCING_CENTER - Name of the center which conducted sequencing (phv00430035.v1.p1)
- SOURCE_SUBJECT_ID - Subject ID used in the Source Repository (phv00430795.v1.p1)
- SUBJECT_ID - Subject ID (phv00430012.v1.p1)
- SUBJECT_ID - Subject ID (phv00430019.v1.p1)
- SUBJECT_ID - Subject ID (phv00430009.v1.p1)
- SUBJECT_ID - Subject ID (phv00430017.v1.p1)
- SUBJECT_SOURCE - Source repository where subjects originate (phv00430794.v1.p1)